Artículos de revistas sobre el tema "Highly Upregulated in Liver Carcinoma"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Highly Upregulated in Liver Carcinoma".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Wadkin, James C. R., Daniel A. Patten, Sivesh K. Kamarajah, Emma L. Shepherd, Vera Novitskaya, Fedor Berditchevski, David H. Adams, Chris J. Weston y Shishir Shetty. "CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma". American Journal of Physiology-Gastrointestinal and Liver Physiology 313, n.º 2 (1 de agosto de 2017): G138—G149. http://dx.doi.org/10.1152/ajpgi.00411.2016.
Texto completoJiang, Xue y Weiwei Liu. "Long Noncoding RNA Highly Upregulated in Liver Cancer Activates p53-p21 Pathway and Promotes Nasopharyngeal Carcinoma Cell Growth". DNA and Cell Biology 36, n.º 7 (julio de 2017): 596–602. http://dx.doi.org/10.1089/dna.2017.3686.
Texto completoYang, Shuang, Jian Zhou, Weiwu Gao, Xia Yang, Di Yang, Zhiqiang Tian, Yuzhang Wu, Mengjie Zhang, Yi Zhang y Bing Ni. "Multifunctional YY1 in Liver Diseases". Seminars in Liver Disease 37, n.º 04 (noviembre de 2017): 363–76. http://dx.doi.org/10.1055/s-0037-1607451.
Texto completoHenderson, James M., Michelle S. W. Xiang, Jiali Carrie Huang, Stefanie Wetzel, Linxuan Jiang, Jack H. Lai, Wengen Wu et al. "Dipeptidyl Peptidase Inhibition Enhances CD8 T Cell Recruitment and Activates Intrahepatic Inflammasome in a Murine Model of Hepatocellular Carcinoma". Cancers 13, n.º 21 (1 de noviembre de 2021): 5495. http://dx.doi.org/10.3390/cancers13215495.
Texto completoRuan, Lingjuan, Lifei Huang, Lilai Zhao, Qiang Wang, Xiaocheng Pan, Anmin Zhang, Qiuping Bai y Zongjun Lv. "The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients". Gastroenterology Research and Practice 2018 (4 de diciembre de 2018): 1–6. http://dx.doi.org/10.1155/2018/9187316.
Texto completoHuynh, Kenneth N., Sriram Rao, Bradley Roth, Theodore Bryan, Dayantha M. Fernando, Farshid Dayyani, David Imagawa y Nadine Abi-Jaoudeh. "Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma". Cancers 15, n.º 10 (12 de mayo de 2023): 2738. http://dx.doi.org/10.3390/cancers15102738.
Texto completoLi, Duguang, Junhai Pan, Yiyin Zhang, Yirun Li, Shengxi Jin, Cheng Zhong, Peng Chen et al. "C8orf76 Modulates Ferroptosis in Liver Cancer via Transcriptionally Up-Regulating SLC7A11". Cancers 14, n.º 14 (13 de julio de 2022): 3410. http://dx.doi.org/10.3390/cancers14143410.
Texto completoKim, Wantae, Sanjoy Kumar Khan, Yuchen Liu, Ruoshi Xu, Ogyi Park, Yong He, Boksik Cha, Bin Gao y Yingzi Yang. "Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma". Gut 67, n.º 9 (2 de septiembre de 2017): 1692–703. http://dx.doi.org/10.1136/gutjnl-2017-314061.
Texto completoCorreia de Sousa, Marta, Nicolas Calo, Cyril Sobolewski, Monika Gjorgjieva, Sophie Clément, Christine Maeder, Dobrochna Dolicka et al. "Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis". Cancers 13, n.º 19 (4 de octubre de 2021): 4983. http://dx.doi.org/10.3390/cancers13194983.
Texto completoXie, Hui, Hongwei Ma y Danqiu Zhou. "Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma". BioMed Research International 2013 (2013): 1–5. http://dx.doi.org/10.1155/2013/136106.
Texto completoLiu, Zhenrong, Yaru Wang, Zulihumaer Aizimuaji, Sheng Ma y Ting Xiao. "Elevated FOXA1 Expression Indicates Poor Prognosis in Liver Cancer due to Its Effects on Cell Proliferation and Metastasis". Disease Markers 2022 (5 de agosto de 2022): 1–16. http://dx.doi.org/10.1155/2022/3317315.
Texto completoHan, Sanfeng, Tao Ye, Yuqin Mao, Bo Hu y Chen Wang. "Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma". Disease Markers 2023 (11 de mayo de 2023): 1–17. http://dx.doi.org/10.1155/2023/5552798.
Texto completoLopez, Samantha, Adithya Anilkumar, Kyle Doxtater, Sudhir Kotnala, Neeraj Chauhan, Murali Yallapu, Meena Jaggi, Subhash Chauhan y Manish Tripathi. "Abstract 544: Role of an ankyrin domain protein in hepatocellular carcinoma progression". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 544. http://dx.doi.org/10.1158/1538-7445.am2022-544.
Texto completoLiu, Kairui, Xiaolin Wu, Xian Zang, Zejian Huang, Zeyu Lin, Wenliang Tan, Xiang Wu, Wenrou Hu, Baoqi Li y Lei Zhang. "Erratum". Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 28, n.º 5 (10 de diciembre de 2020): 559–60. http://dx.doi.org/10.3727/096504020x16032056440102.
Texto completoSuzuki-Kemuriyama, Noriko, Akari Abe, Sae Nakane, Megumi Yuki, Katsuhiro Miyajima y Dai Nakae. "Nonalcoholic steatohepatitis-associated hepatocarcinogenesis in mice fed a modified choline-deficient, methionine-lowered, L-amino acid-defined diet and the role of signal changes". PLOS ONE 18, n.º 8 (3 de agosto de 2023): e0287657. http://dx.doi.org/10.1371/journal.pone.0287657.
Texto completoLu, I.-Ta, Shih-Chao Lin, Yi-Chia Chu, Ya Wen, You-Cheng Lin, Wen-Chien Cheng, Jyh-Horng Sheu y Chi-Chien Lin. "(−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma". Marine Drugs 20, n.º 2 (29 de enero de 2022): 109. http://dx.doi.org/10.3390/md20020109.
Texto completoKrizanac, Marinela, Paola Berenice Mass Sanchez, Sarah K. Schröder, Ralf Weiskirchen y Anastasia Asimakopoulos. "Lipid-Independent Regulation of PLIN5 via IL-6 through the JAK/STAT3 Axis in Hep3B Cells". International Journal of Molecular Sciences 24, n.º 8 (13 de abril de 2023): 7219. http://dx.doi.org/10.3390/ijms24087219.
Texto completoWu, Hao, Zhixin Zhang, Xinyu Han, Sai Zhang, Jinrui Zhang, Pinsheng Han, Youcheng Zhang, Yi Bai y Yamin Zhang. "Upregulated SSB Is Involved in Hepatocellular Carcinoma Progression and Metastasis through the Epithelial-Mesenchymal Transition, Antiapoptosis, and Altered ROS Level Pathway". Oxidative Medicine and Cellular Longevity 2023 (4 de febrero de 2023): 1–16. http://dx.doi.org/10.1155/2023/5207431.
Texto completoGouthamchandra, K., Anuj Kumar, Shivaprasad Shwetha, Anirban Mukherjee, Madhavi Chandra, B. Ravishankar, M. N. Khaja, Provash Chandra Sadhukhan y Saumitra Das. "Serum proteomics of hepatitis C virus infection reveals retinol-binding protein 4 as a novel regulator". Journal of General Virology 95, n.º 8 (1 de agosto de 2014): 1654–67. http://dx.doi.org/10.1099/vir.0.062430-0.
Texto completoLi, Jiahao, Lansi Chen, Jingjing Pang, Chunxiu Yang, Wen Xie, Guoyan Shen, Hongshan Chen, Xiaoyi Li, Shu-Yuan Xiao y Yueying Li. "Autophagy-Related Gene WD Repeat Domain 45B Promotes Tumor Proliferation and Migration of Hepatocellular Carcinoma through the Akt/mTOR Signaling Pathway". Diagnostics 13, n.º 5 (27 de febrero de 2023): 906. http://dx.doi.org/10.3390/diagnostics13050906.
Texto completoÖnlen Güneri, Cansu, Hamza Malik Okuyan, Gülay Gülbol Duran y Mehmet Demir. "Investigation of LncRNAs expression in patients with hepatitis B virus". Journal of Clinical Medicine of Kazakhstan 19, n.º 6 (30 de diciembre de 2022): 27–31. http://dx.doi.org/10.23950/jcmk/12662.
Texto completoWang, Gang, Xuefeng Li, Hongyan Jia, Lei Zhang, Yang Li, Qiuxue Zhang y Meng Lu. "Curcumin nanocarrier carrying si-TAR-RNA binding protein (TRBP) restricts development of hepatocellular carcinoma". Materials Express 13, n.º 3 (1 de marzo de 2023): 407–13. http://dx.doi.org/10.1166/mex.2023.2368.
Texto completoKitab, Bouchra y Kyoko Tsukiyama-Kohara. "Regulatory Role of Ribonucleotide Reductase Subunit M2 in Hepatocyte Growth and Pathogenesis of Hepatitis C Virus". International Journal of Molecular Sciences 24, n.º 3 (30 de enero de 2023): 2619. http://dx.doi.org/10.3390/ijms24032619.
Texto completoKhan, Walizeb, Washaakh Ahmad, Anwar M. Hashem, Shadi Zakai, Shafiul Haque, Muhammad Faraz Arshad Malik, Steve Harakeh y Farhan Haq. "Genomic Relevance of FGFR2 on the Prognosis of HCV-Induced Hepatocellular Carcinoma Patients". Journal of Clinical Medicine 11, n.º 11 (30 de mayo de 2022): 3093. http://dx.doi.org/10.3390/jcm11113093.
Texto completoTao, Hanchuan, Cheng Wang, Chongmei Lu, Ning Ma, Yifan Zhu, Shihai Xuan y Xiaojun Zhou. "Comprehensive Analysis on the Specific Role and Function of Mitochondrial Inner Membrane Protein MPV17 in Liver Hepatocellular Carcinoma". Genetics Research 2022 (19 de julio de 2022): 1–14. http://dx.doi.org/10.1155/2022/7236823.
Texto completoLi, Jianguo, Jin Zhou, Shuangshuang Kai, Can Wang, Daijun Wang y Jiying Jiang. "Network-Based Coexpression Analysis Identifies Functional and Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma". BioMed Research International 2020 (6 de octubre de 2020): 1–11. http://dx.doi.org/10.1155/2020/1371632.
Texto completoLi, Ru, Hikari Okada, Taro Yamashita, Kouki Nio, Han Chen, Yingyi Li, Tetsuro Shimakami et al. "FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition". International Journal of Molecular Sciences 23, n.º 15 (27 de julio de 2022): 8305. http://dx.doi.org/10.3390/ijms23158305.
Texto completoOng, Jiann Ruey, Oluwaseun Adebayo Bamodu, Nguyen Viet Khang, Yen-Kuang Lin, Chi-Tai Yeh, Wei-Hwa Lee y Yih-Giun Cherng. "SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic Cancer Metabolism Biomarker of Hepatocellular Carcinoma". Cells 10, n.º 1 (17 de enero de 2021): 178. http://dx.doi.org/10.3390/cells10010178.
Texto completoJang, Jeong Won, Ji Min Kim, Hye Seon Kim, Jin Seoub Kim, Ji Won Han, Soon Kyu Lee, Heechul Nam et al. "Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma". Journal of Liver Cancer 22, n.º 1 (31 de marzo de 2022): 30–39. http://dx.doi.org/10.17998/jlc.2022.02.25.
Texto completoYang, Yi, Ming Yang, Huasheng Pang, Yiwen Qiu, Ting Sun, Tao Wang, Shu Shen y Wentao Wang. "A Macrophage Differentiation-Mediated Gene: DDX20 as a Molecular Biomarker Encompassing the Tumor Microenvironment, Disease Staging, and Prognoses in Hepatocellular Carcinoma". Oxidative Medicine and Cellular Longevity 2022 (5 de octubre de 2022): 1–22. http://dx.doi.org/10.1155/2022/9971776.
Texto completoPaslaru, Liliana, Gabriela Bindea, Anca Nastase, Andrei Sorop, Cristian Zimbru, Vlad Herlea, Doina Hrehoret et al. "Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology". Medicina 58, n.º 12 (7 de diciembre de 2022): 1803. http://dx.doi.org/10.3390/medicina58121803.
Texto completoPár, Alajos y Gabriella Pár. "Alkoholos májbetegség: a genetikai-epigenetikai tényezők szerepe és az absztinencia hatása". Orvosi Hetilap 160, n.º 14 (abril de 2019): 524–32. http://dx.doi.org/10.1556/650.2019.31352.
Texto completoYuan, Hongchao, Yuanjun Lu, Yau-Tuen Chan, Cheng Zhang, Ning Wang y Yibin Feng. "The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development". Cancers 13, n.º 22 (14 de noviembre de 2021): 5700. http://dx.doi.org/10.3390/cancers13225700.
Texto completoLi, Yaqun, Wenhuan Fu, Zikai Geng, Yun Song, Xionggang Yang, Tianye He, Jian Wu y Bin Wang. "A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors". PeerJ 10 (28 de noviembre de 2022): e14432. http://dx.doi.org/10.7717/peerj.14432.
Texto completoHuang, Shuai, Xiangkun Wang, Kai Luo, Xudong Zhang, Zhongyuan Liu y Renfeng Li. "Combined Evaluation of mRNA and Protein Expression, Promoter Methylation, and Immune Infiltration of UBE2I in Pan-Digestive System Tumors". Oxidative Medicine and Cellular Longevity 2022 (20 de septiembre de 2022): 1–20. http://dx.doi.org/10.1155/2022/1129062.
Texto completoFang, Xiaona, Shan Liu, Liuxian Ban, Jiao Huang, Jie Luo, Lanqi Gong, Baifeng Zhang et al. "Abstract 2441: Identification and characterization of the role of KRT17 in the stemness regulation of hepatocellular carcinoma". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 2441. http://dx.doi.org/10.1158/1538-7445.am2023-2441.
Texto completoSakamoto, Yuzuru, Sachiyo Yoshio, Akihisa Nagatsu, Yoh Asahi, Shingo Shimada, Tatsuya Orimo, Hirofumi Kamachi, Toshiya Kamiyama, Tatsuya Kanto y Akinobu Taketomi. "Increased frequency of PD-1+CD57+Siglec-7- dysfunctional NK cells in patients with nonalcoholic fatty liver disease." Journal of Clinical Oncology 38, n.º 4_suppl (1 de febrero de 2020): 589. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.589.
Texto completoBeaumont, Jamie, Eric Aboagye, Beata Wojciak-Stothard, Gilberto Serrano-De-Almeida, Robert Glen y Rohini Sharma. "Abstract 5398: Apelinergic signalling in hepatocellular carcinoma (HCC): A new therapeutic treatment option". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 5398. http://dx.doi.org/10.1158/1538-7445.am2022-5398.
Texto completoLiu, Jun, Zheng Chen y Wenli Li. "Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients". Journal of Oncology 2021 (17 de marzo de 2021): 1–15. http://dx.doi.org/10.1155/2021/6676537.
Texto completoJung, Ji Hoon, Hyo-Jung Lee, Ju-Ha Kim, Deok Yong Sim, Eunji Im, Sinae Kim, Suhwan Chang y Sung-Hoon Kim. "Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2". Cells 9, n.º 4 (16 de abril de 2020): 985. http://dx.doi.org/10.3390/cells9040985.
Texto completoZhang, Hailong. "Abstract B031: PRC2 inhibitor suppresses angiogenesis in Hepatocellular carcinoma (HCC) by up-regulation of anti-angiogenic factors vasohibin1 (VASH1) and tissue inhibitor of metalloproteinases 3 (TIMP-3)". Cancer Research 82, n.º 23_Supplement_2 (1 de diciembre de 2022): B031. http://dx.doi.org/10.1158/1538-7445.cancepi22-b031.
Texto completoVijay-Kumar, Matam, Beng San Yeoh, Vishal Singh, Rachel M. Golonka y Piu Saha. "Dietary Soluble Fiber Induces HCC in Dysbiotic Mice Through a Spectrum of Immunosuppressive Mediators". Journal of Immunology 202, n.º 1_Supplement (1 de mayo de 2019): 59.3. http://dx.doi.org/10.4049/jimmunol.202.supp.59.3.
Texto completoDuffy, Austin G., Osama E. Rahma, Susanna Varkey Ulahannan, Suzanne Fioravanti, Aradhana Venkatesan, Ismail B. Turkbey, Peter L. Choyke, Jane B. Trepel, William Douglas Figg y Tim F. Greten. "A phase II study of TR105 in patients with hepatocellular carcinoma (HCC) who have progressed on sorafenib." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): e15177-e15177. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e15177.
Texto completoKwon, Young-Chan, Sandip K. Bose, Robert Steele, Keith Meyer, Adrian M. Di Bisceglie, Ratna B. Ray y Ranjit Ray. "Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes". Journal of Virology 89, n.º 22 (9 de septiembre de 2015): 11549–56. http://dx.doi.org/10.1128/jvi.01946-15.
Texto completoVerslype, Chris, Hannah van Malenstein, Jeroen Dekervel, Petra Windmolders, Louis Libbrecht, Rudy van Eijsden, Frederik Nevens y Jos van Pelt. "Resistance development after long-term sorafenib exposure in hepatocellular cancer cell lines and risk of rebound growth and epithelial to mesenchymal transition." Journal of Clinical Oncology 30, n.º 4_suppl (1 de febrero de 2012): 216. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.216.
Texto completoWeinberger, Paul, Sithara Raju Ponny, Hongyan Xu, Shan Bai, Robert Smallridge, John Copland y Ashok Sharma. "Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma". Thyroid 27, n.º 2 (febrero de 2017): 236–52. http://dx.doi.org/10.1089/thy.2016.0285.
Texto completoPaganoni, Rossana, André Lechel y Maja Vujic Spasic. "Iron at the Interface of Hepatocellular Carcinoma". International Journal of Molecular Sciences 22, n.º 8 (15 de abril de 2021): 4097. http://dx.doi.org/10.3390/ijms22084097.
Texto completoLiang, Zenghui, Yingtang Gao, Wenxia Shi, Daokuan Zhai, Shilei Li, Li Jing, Hua Guo, Tong Liu, Yajie Wang y Zhi Du. "Expression and Significance of MicroRNA-183 in Hepatocellular Carcinoma". Scientific World Journal 2013 (2013): 1–6. http://dx.doi.org/10.1155/2013/381874.
Texto completoMatouk, Imad J., Ibrahim Abbasi, Abraham Hochberg, Eithan Galun, Hassan Dweik y Mutaz Akkawi. "Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis". European Journal of Gastroenterology & Hepatology 21, n.º 6 (junio de 2009): 688–92. http://dx.doi.org/10.1097/meg.0b013e328306a3a2.
Texto completoGhafouri‐Fard, Soudeh, Mohammadhosein Esmaeili, Mohammad Taheri y Majid Samsami. "Highly upregulated in liver cancer (HULC): An update on its role in carcinogenesis". Journal of Cellular Physiology 235, n.º 12 (5 de mayo de 2020): 9071–79. http://dx.doi.org/10.1002/jcp.29765.
Texto completo